eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | severe combined immunodeficiency |
| Comorbidity | C0024299|lymphoma |
| Sentences | 6 |
| PubMedID- 24634778 | Mouse efficacy studies in scid mice engrafted with disseminated lymphoma showed very high anti-tumor activity that was more than 50-fold more potent than that of rituximab, or the combination of rituximab and il2 [85]. |
| PubMedID- 24098639 | Bjab cells were able to develop a human/mouse model of lymphoma in scid mice. |
| PubMedID- 23326467 | The anti-tumor activity of expanded human nk cells was examined in scid mice injected with human lymphoma cells. |
| PubMedID- 22589397 | Severe combined immunodeficient (scid) mice inoculated with human cd27-expressing lymphoma cells were administered 1f5 to investigate direct antitumor effects. |
| PubMedID- 21657960 | Adoptive transfer of the ctls to scid mice loaded with qlvqsgaev(+)/hla-a2.1(+) lymphoma cells effectively inhibited tumor growth. |
| PubMedID- 25962508 | A preclinical study reported that the survival of severe combined immunodeficient mice injected with human lymphoma cells could be significantly prolonged after receiving cik cell infusion [19]. |
Page: 1